Australia's Arovella Therapeutics hits 2-week high after new CFO appointed

Arovella Therapeutics

01/12/2023 03:31

** Shares of Arovella Therapeutics Ltd  ALA.AX  rise as much
as 5.4% to A$0.097, their highest since Nov. 16 
    ** Biotechnology co says it has appointed Tim Luscombe as
CFO and Company Secretary, effective Dec. 1 
    ** Stock marks first week of gains in three; up nearly 10.5%
for the week so far
    ** ALA on track to mark its best week since Oct. 27
    ** Stock up 300% this year, as of last close

 (Reporting by Neha Soni in Bengaluru)
 ((Neha.Soni@thomsonreuters.com))